Genetic investigation for adults with intellectual disability: Opportunities and challenges

Current Opinion in Neurology

Volumn 25, Issue 2, 2012, Pages 150-158

  Baker, Kate ^a   Raymond, F Lucy ^a   Bass, Nick ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adults; Diagnosis; Genetics; Intellectual disability

Indexed keywords

ADULT; BLOOD SAMPLING; BRAIN MALFORMATION; CARDIOMYOPATHY; CHROMOSOME DELETION 22Q11; CONGENITAL MALFORMATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; FLUORESCENCE IN SITU HYBRIDIZATION; FRAGILE X SYNDROME; GENE DELETION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC SCREENING; HEART ARRHYTHMIA; HUMAN; IDIOPATHIC DISEASE; INTELLECTUAL IMPAIRMENT; KARYOTYPING; KIDNEY POLYCYSTIC DISEASE; MOLECULAR DIAGNOSIS; MOSAICISM; NEUROFIBROMATOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE; NUTRITIONAL DEFICIENCY; PENETRANCE; PERINATAL ASPHYXIA; PHENOTYPE; PRENATAL DIAGNOSIS; REVIEW; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; X CHROMOSOME LINKED DISORDER;

GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTELLECTUAL DISABILITY; MICROARRAY ANALYSIS;

EID: 84859755049     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328351820e     Document Type: Review

References (85)

1. Schalock R, Borthwick-Duffy SA, Bradley VJ, et al. Intellectual disability: definition, classification, and systems of supports. 11th ed. American Association on Intellectual and Developmental Disabilities; 2010.
2. Shevell M, Majnemer A, Platt RW, et al. Developmental and functional outcomes at school age of preschool children with global developmental delay. J Child Neurol 2005; 20:648-653.
3. Maulik PK, Mascarenhas MN, Mathers CD, et al. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 2011; 32:419-436.
4. Durkin M. The epidemiology of developmental disabilities in low-income countries. Ment Retard Dev Disabil Res Rev 2002; 8:206-211. (Pubitemid 36378163)
5. Jauhari P, Boggula R, Bhave A, et al. Aetiology of intellectual disability in paediatric outpatients in Northern India. Dev Med Child Neurol 2011; 53:167-172.
6. Curry CJ, Stevenson RE, Aughton D, et al. Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 1997; 72:468-477. (Pubitemid 27471338)
7. van Karnebeek CD, Jansweijer MC, Leenders AG, et al. Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet 2005; 13:6-25.
8. Shaffer LG. American College of Medical Genetics guideline on the cytoge-netic evaluation of the individual with developmental delay or mental retardation. Genet Med 2005; 7:650-654. (Pubitemid 41753018)
9. Hunter AG. Outcome of the routine assessment of patients with mental retardation in a genetics clinic. Am J Med Genet 2000; 90:60-68. (Pubitemid 30010831)
10. Battaglia A, Bianchini E, Carey JC. Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an institute of child neuropsychiatry. Am J Med Genet 1999; 82:60-66. (Pubitemid 29022301)
11. Seibert D, Hong CH, Takeuchi F, et al. Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences. Ann Intern Med 2011; 154:806-813.
12. Winter RM, Baraitser M. Winter-Baraitser dysmorphology database (WBDD). London Medical Databases; 2011.
13. Victorian Clinical Genetics Services. Pictures of standard syndromes and undiagnosed malformations (POSSUM) 2010. http://www.possum.net.au/.
14. McKusick-Nathans Institute of Genetic Medicine JHUSoM. Online Mendelian inheritance in man 2011. http://www.ncbi.nlm.nih.gov/omim.
15. O'Driscoll MC, Black GC, Clayton-Smith J, et al. Identification of genomic loci contributing to agenesis of the corpus callosum. Am J Med Genet A 2010; 152A:2145-2159.
16. Guerrini R, Parrini E. Neuronal migration disorders. Neurobiol Dis 2010; 38:154-166.
17. Dixon-Salazar TJ, Gleeson JG. Genetic regulation of human brain development: lessons from Mendelian diseases. Ann N YAcad Sci 2010; 1214:156-167.
18. Pearl PL, Shukla L, Theodore WH, et al. Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. Brain Dev 2011; 33:796-805.
19. Boucek D, Jirikowic J, Taylor M. Natural history of Danon disease. Genet Med 2011; 13:563-568.
20. Sattar S, Gleeson JG. The ciliopathies in neuronal development: a clinical approach to investigation of Joubert syndrome and Joubert syndrome-related disorders. Dev Med Child Neurol 2011; 53:793-798.
21. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with develop mental disabilities or congenital anomalies. Am J Hum Genet 2010; 86:749-764.
22. Cooper GM, Coe BP, Girirajan S,et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011; 43:838-846.
23. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444:444-454. (Pubitemid 44809057)
24. Carter NP. Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet 2007; 39:S16-S21. (Pubitemid 47014471)
25. Liu P, Erez A, Nagamani SC, et al. Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. Hum Mol Genet 2011; 20:1975-1988.
26. The Centre for Applied Genomics. Database of genomic variants 2011. http://projects.tcag.ca/variation/.
27. Firth HV, Richards SM, Bevan AP, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensemble resources. Am J Hum Genet 2009; 84:524-533.
28. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466:368-372.
29. Gilman SR, Iossifov I, Levy D, et al. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011; 70:898-907.
30. Shaikh TH, Haldeman-Englert C, Geiger EA, et al. Genes and biological processes commonly disrupted in rare and heterogeneous developmental delay syndromes. Hum Mol Genet 2011; 20:880-893.
31. Vermeesch JR, Balikova I, Schrander-Stumpel C, et al. The causality of de novo copy number variants is overestimated. Eur J Hum Genet 2011; 19:1112-1113.
32. Michelson DJ, Shevell MI, Sherr EH, et al. Evidence report: genetic and metabolic testing on children with global developmental delay: report of the QualityStandards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2011; 77:1629-1635.
33. Lundvall M, Rajaei S, Erlandson A, Kyllerman M. Aetiology of severe mental retardation and further genetic analysis by high-resolution microarray in a population-based series of 6-to 17-year-old children. Acta Paediatr 2011; 101:85-91.
34. Wincent J, Anderlid BM, Lagerberg M, et al. High-resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting. Clin Genet 2011; 79:147-157.
35. Mefford HC, Muhle H, Ostertag P, et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010; 6:e1000962.
36. Heinzen EL, Radtke RA, Urban TJ, et al. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 2010; 86:707-718.
37. Striano P, Coppola A, Paravidino R, et al. Clinical significance of rare copy number variations in epilepsy: a case-control survey using microarray-based comparative genomic hybridization. Arch Neurol 2011. [Epub ahead of print]
38. Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011; 70:863-885.
39. Sahoo T, Theisen A, Rosenfeld JA, et al. Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet Med 2011; 13:868-880.
40. Schluth-Bolard C, Delobel B, Sanlaville D, et al. Cryptic genomic imbalances in de novo and inherited apparently balanced chromosomal rearrangements: array CGH study of 47 unrelated cases. Eur J Med Genet 2009; 52:291-296.
41. Kariminejad R, Lind-Thomsen A, Tumer Z, et al. High frequency of rare copy number variants affecting functionally related genes in patients with structural brain malformations. Hum Mutat 2011; 32:1427-1435.
42. Hayashi S, Imoto I, Aizu Y, et al. Clinical application of array-based comparative genomic hybridization by two-stage screening for 536 patients with mental retardation and multiple congenital anomalies. J Hum Genet 2011; 56:110-124.
43. Bassett AS, Donald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011; 159:332-339.
44. van Bon BW, Mefford HC, Menten B, et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from nonpathogenic to a severe outcome. J Med Genet 2009; 46:511-523.
45. Burnside RD, Pasion R, Mikhail FM, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neuro logical dysfunction including developmental and language delay. Hum Genet 2011; 130:517-528.
46. Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010; 47:332-341.
47. Jacquemont S, Reymond A, Zufferey F, et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 2011; 478:97-102.
48. Girirajan S, Rosenfeld JA, Cooper GM, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 2010; 42:203-209.
49. Battaglia A, Hoyme HE, Dallapiccola B, et al. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 2008; 121:404-410. (Pubitemid 351198468)
50. van Bon BW, Koolen DA, Brueton L, et al. The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype. Eur J Hum Genet 2010; 18:163-170.
51. Willatt L, Cox J, Barber J, et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet 2005; 77:154-160. (Pubitemid 40848047)
52. Kleefstra T, van Zelst-Stams WA, Nillesen WM, et al. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet 2009; 46:598-606.
53. Koolen DA, Sharp AJ, Hurst JA, et al. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet 2008; 45:710-720.
54. Guilmatre A, Dubourg C, Mosca AL, et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 2009; 66:947-956.
55. Tarpey PS, Smith R, Pleasance E, et al. A systematic, large-scale resequen-cing screen of X-chromosome coding exons in mental retardation. Nat Genet 2009; 41:535-543.
56. Gecz J, Shoubridge C, Corbett M. The genetic landscape of intellectual disability arising from chromosome X. Trends Genet 2009; 25:308-316.
57. Hamdan FF, Gauthier J, Araki Y, et al. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 2011; 88:306-316.
58. Sirmaci A, Walsh T, Akay H, et al. MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. Am J Hum Genet 2010; 87:679-686.
59. Sirmaci A, Spiliopoulos M, Brancati F, et al. Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malforma tions, and macrodontia. Am J Hum Genet 2011; 89:289-294.
60. Bilguvar K, Ozturk AK, Louvi A, et al. Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations. Nature 2010; 467:207-210.
61. Caliskan M, Chong JX, Uricchio L, et al. Exome sequencing reveals a novel mutation for autosomal recessive nonsyndromic mental retardation in the TECR gene on chromosome 19p13. Hum Mol Genet 2011; 20:1285-1289.
62. Vissers LE, de LJ, Gilissen C, Janssen I, et al. A de novo paradigm for mental retardation. Nat Genet 2010; 42:1109-1112.
63. Najmabadi H, Hu H, Garshasbi M, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011; 478:57-63.
64. Nowakowska BA, de Leeuw N, Ruivenkamp CA, et al. Parental insertional balanced translocations are an important cause of apparently de novo CNVs in patients with developmental anomalies. Eur J Hum Genet 2012; 20:166-170.
65. Bruno DL, White SM, Ganesamoorthy D, et al. Pathogenic aberrations revealed exclusively by single nucleotide polymorphism (SNP) genotyping data in 5000 samples tested by molecular karyotyping. J Med Genet 2011; 48:831-839.
66. Raymond FL, Whibley A, Stratton MR, Gecz J.Lessons learnt from large-scale exon re-sequencing of the X chromosome. Hum Mol Genet 2009; 18:R60-R64.
67. Almomani R, van der HJ, Ariyurek Y, et al. Experiences with array-based sequence capture; toward clinical applications. Eur J Hum Genet 2011; 19:50-55.
68. Vos J, Otten W, van AC J, et al. The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life. Psychooncology 2008; 17:822-830.
69. Tucker T, Montpetit A, Chai D, et al. Comparison of genome-wide array genomic hybridization platforms for the detection of copy number variants in idiopathic mental retardation. BMC Med Genomics 2011; 4:25.
70. Millson A, Lagrave D, Willis MJ, et al. Chromosomal loss of 3q26.3-3q26.32, involving a partial neuroligin 1 deletion, identified by genomic microarray in a child with microcephaly, seizure disorder, and severe intellectual disability. Am J Med Genet A 2011. [Epub ahead of print]
71. Lupski JR, Reid JG, Gonzaga-Jauregui C, et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 2010; 362:1181-1191.
72. Limb L, Nuttland S, Sen A. Experiences of rare diseases: an insight from patients and families 2010. Rare Disease UK (RDUK). http://www.rarediseases.uk.
73. Jefferies JL, Pignatelli RH, Martinez HR, et al. Cardiovascular findings in duplication 17p11.2 syndrome. Genet Med 2011. [Epub ahead of print]
74. Merla G, Brunetti-Pierri N, Micale L, Fusco C. Copy number variants at Williams-Beuren syndrome 7q11.23 region. Hum Genet 2010; 128:3-26.
75. Ball SL, Holland AJ, Hon J, et al. Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study. Int J Geriatr Psychiatry 2006; 21:661-673. (Pubitemid 44122075)
76. Garbern JY, Neumann M, Trojanowski JQ, et al. A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. Brain 2010; 133:1391-1402.
77. Verhoeven WM, Egger JI, Vermeulen K, et al. Kleefstra syndrome in three adult patients: further delineation of the behavioral and neurological phenotype shows aspects of a neurodegenerative course. Am J Med Genet A 2011; 155A:2409-2415.
78. Kasperaviciute D, Catarino CB, Chinthapalli K, et al. Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions. PLoS One 2011; 6:e23182.
79. Tyrer F, Smith LK, McGrother CW. Mortality in adults with moderate to profound intellectual disability: a population-based study. J Intellect Disabil Res 2007; 51:520-527. (Pubitemid 47097242)
80. Catarino CB, Liu JY, Liagkouras I, et al. Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain 2011; 134:2982-3010.
81. Ehninger D, Li W, Fox K, et al. Reversing neurodevelopmental disorders in adults. Neuron 2008; 60:950-960.
82. Krab LC, de Goede-Bolder A, Aarsen FK, et al. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. J Am Med Assoc 2008; 300:287-294. (Pubitemid 352008645)
83. Krueger DD, Bear MF. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 2011; 62:411-429.
84. Shashi V, Veerapandiyan A, Schoch K, et al. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions. J Intellect Disabil Res 2011. [Epub ahead of print]
85. Sullivan WF, Berg JM, Bradley E, et al. Primary care of adults with developmental disabilities: Canadian consensus guidelines. Can Fam Physician 2011; 57:541-568.